Cargando…

Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH

Dysregulation of glucose homeostasis plays a major role in the pathogenesis of non-alcoholic steatohepatitis (NASH) as it activates proinflammatory and profibrotic processes. Beneficial effects of antiglycemic treatments such as GLP-1 agonist or SGLT-2 inhibitor on NASH in patients with diabetes hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hupa-Breier, Katharina Luise, Dywicki, Janine, Hartleben, Björn, Wellhöner, Freya, Heidrich, Benjamin, Taubert, Richard, Mederacke, Young-Seon Elisabeth, Lieber, Maren, Iordanidis, Konstantinos, Manns, Michael P., Wedemeyer, Heiner, Hardtke-Wolenski, Matthias, Jaeckel, Elmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066839/ https://www.ncbi.nlm.nih.gov/pubmed/33808404 http://dx.doi.org/10.3390/biomedicines9040353

Ejemplares similares

Splenectomy induces biochemical remission and regeneration in experimental murine autoimmune hepatitis
por: Dywicki, Janine, et al.
Publicado: (2022)

The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis
por: Dywicki, Janine, et al.
Publicado: (2021)

Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration
por: Buitrago-Molina, Laura Elisa, et al.
Publicado: (2021)

Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis
por: Buitrago-Molina, Laura Elisa, et al.
Publicado: (2021)

Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis
por: John, Katharina, et al.
Publicado: (2017)

Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors
por: Kremer, Jakob, et al.
Publicado: (2022)

Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies
por: Höfer, Anne, et al.
Publicado: (2020)

Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells
por: Derben, Finn C., et al.
Publicado: (2023)

Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2017)

Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
por: Wranke, Anika, et al.
Publicado: (2023)

The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
por: Malkin, Samuel J. P., et al.
Publicado: (2022)

Alloantigen-Induced Regulatory T Cells Generated in Presence of Vitamin C Display Enhanced Stability of Foxp3 Expression and Promote Skin Allograft Acceptance
por: Nikolouli, Eirini, et al.
Publicado: (2017)

PD-1/CTLA-4 Blockade Leads to Expansion of CD8(+)PD-1(int) TILs and Results in Tumor Remission in Experimental Liver Cancer
por: Bufe, Sandra, et al.
Publicado: (2022)

Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model
por: Park, Hye Jung, et al.
Publicado: (2019)

Generation of Chimeric Antigen Receptors against Tetraspanin 7
por: Pieper, Tom, et al.
Publicado: (2023)

Association of torque teno virus viremia with liver fibrosis in the first year after liver transplantation
por: Engel, Bastian, et al.
Publicado: (2023)

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018)

Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies
por: Campos-Murguia, Alejandro, et al.
Publicado: (2023)

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

Transient increase of activated regulatory T cells early after kidney transplantation
por: Mederacke, Young-Seon, et al.
Publicado: (2019)

Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth
por: Hardtke-Wolenski, Matthias, et al.
Publicado: (2013)

Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C
por: Khera, Tanvi, et al.
Publicado: (2021)

No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis
por: Engel, Bastian, et al.
Publicado: (2022)

Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy
por: Diestelhorst, Jana, et al.
Publicado: (2017)

HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
por: Sandmann, Lisa, et al.
Publicado: (2021)

Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer’s Disease
por: Saetzler, Valerie, et al.
Publicado: (2023)

Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
por: Kang, Gideon G., et al.
Publicado: (2022)

Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis
por: Diestelhorst, Jana, et al.
Publicado: (2018)

Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales
por: Carter, James K., et al.
Publicado: (2021)

Application of the Liver Maximum Function Capacity Test in Acute Liver Failure: A Helpful Tool for Decision-Making in Liver Transplantation?
por: Vondran, Florian Wolfgang Rudolf, et al.
Publicado: (2016)

Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites
por: Tergast, Tammo L., et al.
Publicado: (2023)

Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
por: Hegazy, Mona A, et al.
Publicado: (2020)

Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model
por: Lützhøft, Ditte Olsen, et al.
Publicado: (2022)

Hypercortisolaemia due to ectopic adrenocorticotropic hormone secretion by a nasal paraganglioma: a case report and review of the literature
por: Thomas, Theodoros, et al.
Publicado: (2013)

Necrotizing Pancreatitis Secondary to Dulaglutide Use
por: Bhat, Salman Zahoor, et al.
Publicado: (2021)

SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis
por: Kirchner, Theresa, et al.
Publicado: (2021)

Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells
por: Garg, Garima, et al.
Publicado: (2017)

Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis
por: Hamberger, Florian, et al.
Publicado: (2022)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v8lq9kniauo2isf7co3gbf2fmf